Developing and applying state-of-the-art mass spectrometry based molecular imaging approaches for nanomedicine and biomedical research, including mass spectrometry as a diagnostic and prognostic tool for personalized medicine in oncology, neurology and cardiovascular medicine.
Frank Nijpels is working on the Vitrojet, a new device that prepares samples for a form of electron microscopy that received the 2017 Nobel Prize in Chemistry.
It’s a major step forward on the road to sustainable agriculture and healthy food.
Researchers from the Maastricht M4I institute, led by Prof. Ron Heeren, are key partners in an international consortium that will validate the iKnife.
The M4I Division of Imaging Mass Spectrometry is one of the world leaders in high resolution molecular imaging of biological surfaces. The division targets the development and application of state-of-the-art mass spectrometry based molecular imaging approaches for biomedical cellular and tissue research. Main research aim for the coming years is to develop and apply mass spectrometry as a diagnostic and prognostic tool for personalized medicine.
The New Dawn of Cancer Surgery |
Ron Heeren | TEDxMaastricht Nov 3, 2016
Pioneer prof. dr. Ron Heeren, University professor at Maastricht University and key player in the Top Research Institute M4I (Maastricht MultiModal Molecular Imaging Institute) is at the forefront of technological breakthroughs in oncology, neurology and cardiovascular medicine. Heeren’s team is developing biomedical applications of Mass Spectroscopy Imaging (MSI), or in other words techniques to photograph molecules.
“To try to understand biomolecules is to try to understand the complexity of life. It’s a puzzle that makes putting a radio together pale in comparison.”
“Imaging mass spectrometry produces huge and complex amount of data; giving sense to that data is what drives me.”